Journal Article

FZJ-2025-02212

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0

Verger, A. (Corresponding author)FZJ* ; Tolboom, N. ; Cicone, F. ; Chang, S. M. ; Furtner, J. ; Galldiks, N.FZJ* ; Gempt, J. ; Guedj, E. ; Huang, R. Y. ; Johnson, D. R. ; Law, I. ; Le Rhun, E. ; Short, S. C. ; Bent, M. J. V. d. ; Weehaeghe, D. V. ; Vogelbaum, M. A. ; Wen, P. Y. ; Albert, N. L. ; Preusser, M.

2025
Springer-Verl. Heidelberg [u.a.]

This record in other databases:      

Please use a persistent id in citations: doi:10.1007/s00259-024-07038-5  doi:10.34734/FZJ-2025-02212

Abstract: This joint practice guideline/procedure standard was collaboratively developed by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neuro-Oncology (EANO), and the PET task force of the Response Assessment in Neurooncology Working Group (PET/RANO). Brain metastases are the most common malignant central nervous system (CNS) tumors. PET imaging with radiolabeled amino acids and to lesser extent [18F]FDG has gained considerable importance in the assessment of brain metastases, especially for the differential diagnosis between recurrent metastases and treatment-related changes which remains a limitation using conventional MRI. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with brain metastases. This practice guideline will define procedure standards for the application of PET imaging in patients with brain metastases in routine practice and clinical trials and will help to harmonize data acquisition and interpretation across centers.Keywords: Brain metastases; Brain metastasis; FDG; FDOPA; FET; Fluciclovine; Metastatic brain tumors; Methionine; PET; Recurrence.

---

Contributing Institute(s):

1. Kognitive Neurowissenschaften (INM-3)

Research Program(s):

1. 5252 - Brain Dysfunction and Plasticity (POF4-525) (POF4-525)

Appears in the scientific report 2025

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---